Siderophore iron transporter 1 (Sit1) (Sit1)

Siderophore iron transporter 1 (Sit1) is a specialized membrane protein belonging to the Major Facilitator Superfamily (MFS), primarily identified in fungal pathogens such as Candida albicans and Cryptococcus neoformans (UniProt: Q59N61, P38356). Its primary biological function is the high-affinity uptake of hydroxamate-type siderophores, such as ferrioxamine B, which allows the fungus to acquire essential iron from the host environment during infection (PubMed: 17464053). Because iron acquisition is indispensable for fungal growth, metabolism, and pathogenicity, Sit1 plays a critical role in the survival and virulence of these organisms within the iron-restricted environment of a human host (PubMed: 12193609). In the context of drug development, Sit1 is a promising target for 'Trojan Horse' strategies, where antifungal agents are conjugated to siderophores to ensure targeted delivery into the fungal cell. Since humans lack a direct Sit1 homolog and do not utilize the same siderophore uptake mechanisms, targeting this transporter offers a pathway for developing highly selective antifungal therapies with minimal off-target effects.

Other names

Arn3Ferrioxamine B transporterSiderophore transporter Sit1ARN3/SIT1Siderophore iron transporter ARN3

Sit1 facilitates the transmembrane transport of iron-siderophore complexes (specifically hydroxamate-type siderophores) into the fungal cytoplasm. This mechanism is exploited in 'Trojan Horse' therapeutic strategies, where antifungal drugs are chemically conjugated to siderophores to be actively and selectively transported into the pathogen (PubMed: 12193609, PubMed: 25103226).